| lncRNA name in article | Virus & Strain Name | Dosage & Time point | Cell line | Experiment Type | Fold change | Expression | P-value | Differential expression quantification method | Statistical method | Year | PubMed ID |
|---|---|---|---|---|---|---|---|---|---|---|---|
| C6orf223 | Influenza A virus (A_Puerto Rico_8_34 (H1N1) strain of IAV) | MOI < 2 ;
24 hr |
Primary Human Bronchial epithelial (NHBE) cells | RNA-Seq | 1.780750006 | Upregulation | 1 | student's t test | 2020 | 32416070 | |
| C6orf223 | Severe acute respiratory syndrome coronavirus 2 (USA-WA1_2020 strain of SARS-CoV-2) | MOI < 2 ;
24 hr |
Calu-3 Human adenocarcinomic lung epithelialcells | RNA-Seq | 2.499899331 | Upregulation | 0.003056358 | student's t test | 2020 | 32416070 | |
| C6orf223 | Severe acute respiratory syndrome coronavirus 2 (USA-WA1_2020 strain of SARS-CoV-2) | MOI < 2 ;
24 hr |
A-549 Human adenocarcinomic alveolar basal epithelial cells | RNA-Seq | 0.457911277 | Downregulation | 3.36E-42 | student's t test | 2020 | 32416070 |
* MOI :Multiplicity of infection , TCID :Tissue Culture Infectious Dose